Position in AXGN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$2,118,042
+$875,502 QoQ
Shares Held
45,855
+22.3% QoQ
Ownership
0.085%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
11 quarters on record
Common Shares in AXGN Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Legato Capital Management LLC holds $28,636,843 across 24 Medical Devices names. AXGN ranks #3 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UFPT |
Ufp Technologies Inc
|
35,301 | $9,359,354 | |
| 2 | BWAY |
Brainsway Ltd.
|
197,635 | $3,065,318 | |
| 3 | AXGN |
Axogen, Inc.
This page
|
45,855 | $2,118,042 | |
| 4 | HAE |
Haemonetics Corp
|
23,450 | $1,758,750 | |
| 5 | APYX |
Apyx Medical Corp
|
382,762 | $1,718,601 | |
| 6 | SIBN |
SI-BONE, Inc.
|
91,361 | $1,491,011 | |
| 7 | MASS |
908 Devices Inc.
|
158,119 | $1,375,635 | |
| 8 | NVCR |
NovoCure Ltd
|
84,810 | $1,284,871 |
All Filings in AXGN
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,118,042 | 45,855 | Shares | Other | 2026-08-06 | |
| 2026-03-31 | $1,242,540 | 37,505 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $1,323,437 | 40,435 | Shares | Other | 2026-02-06 | |
| 2025-03-31 | $943,241 | 50,986 | Shares | Other | 2025-05-06 | |
| 2024-12-31 | $568,955 | 34,524 | Shares | Other | 2025-01-29 | |
| 2024-09-30 | $339,003 | 24,180 | Shares | Other | 2024-11-07 | |
| 2023-12-31 | $759,379 | 111,183 | Shares | Other | 2024-01-16 | |
| 2023-09-30 | $555,915 | 111,183 | Shares | Other | 2023-10-12 | |
| 2023-06-30 | $1,062,750 | 116,402 | Shares | Other | 2023-08-18 | |
| 2023-03-31 | $807,228 | 85,421 | Shares | Other | 2023-05-25 | |
| 2022-12-31 | $852,501 | 85,421 | Shares | Other | 2023-02-01 | |
| No filing history on record for this holder in this stock. | ||||||